Evidence map›Paper›PMID 37894651›Full record

ReviewMolecules (Basel, Switzerland)2023

Advancements in the Biotransformation and Biosynthesis of the Primary Active Flavonoids Derived from

Xiaoling Zhang, Bingling Tang, Sijie Wen, Yitong Wang, Chengxue Pan, Lingbo Qu, Yulong Yin, Yongjun Wei

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
13.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 53 citations in OpenAlex.

  1. Microglia-targetedMaterials today. Bio · 2026
    Article
  2. Review
  3. Review
  4. Rapid Structural Analysis of Natural Products Using MicroED.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  5. Article
  6. Journal of pharmaceutical analysis · 2025
    Review
  7. Review
  8. Article
  9. Exploring the mechanism ofCytotechnology · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Assessing the climate change impact onFrontiers in plant science · 2025
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Xiaoling ZhangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Bingling TangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Sijie WenSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Yitong WangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Chengxue PanSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Lingbo QuCollege of Chemistry, Zhengzhou University, Zhengzhou 450001, China.
Yulong YinInstitute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha 410081, China.
Yongjun WeiLaboratory of Synthetic Biology, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.ORCID 0000-0002-1554-1999
Zhengzhou University · CNChinese Academy of Sciences · CN

Funding

National Natural Science Foundation of China 32101003, 32371485, and 32111530179
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drugs, Chinese HerbalEpimediumOsteoporosisBiotransformationFlavonoidsDrugs, Chinese HerbalFlavonoidsbiosynthesisbiotransformationEpimediumextraction methodsflavonoidspharmacological activities

Identifiers

PMID37894651
PMCPMC10609448
OpenAlexW4387774955

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.